Ara mostrant els elements 51-58 de 58
Bergamino Sirvén, Milana Arantza (Data de defensa: 2022-11-29)
[eng] 80% of breast cancer (BC) express positive estrogen receptors (ER+) and up to 15% of them also overexpress or amplify the human epidermal growth factor receptor 2 (HER2), which confers a molecular ...
Garcia Mulero, Sandra (Data de defensa: 2022-12-16)
[eng] Cancer is a heterogeneous disease, in which many cell types interact with cancer cells, forming a complex network. The crosstalk between the cancer cells and the immune microenvironment is determinant ...
Luján Barroso, Leila (Data de defensa: 2020-07-10)
[spa] Antecedentes: La menopausia es un punto de inflexión en la salud de la mujer y está relacionada con un aumento del riesgo de osteoporosis y enfermedades cardiovasculares. Sin embargo, el riesgo ...
Sierra Agudelo, Jessica Nathalia (Data de defensa: 2024-02-23)
[eng] The emergence of liquid biopsies has been useful for the diagnosis of physiological conditions, inflammatory processes, and especially represents a good alternative tool for non-invasive analysis ...
Playà Albinyana, Heribert (Data de defensa: 2024-04-29)
[eng] Chronic lymphocytic leukemia (CLL) is a prevalent form of leukemia among adults in western countries, marked by a monoclonal mature CD19+ CD5+ B cell expansion in the peripheral blood, secondary ...
Hernández Carro, Claudia (Data de defensa: 2024-03-19)
[eng] Prostate and colorectal cancer are among the cancer types with the highest recurrence and mortality rates. The emergence of drug resistance poses a considerable challenge for effective treatment, ...
Aguado Flor, Ester (Data de defensa: 2024-04-12)
[eng] During radiotherapy (RT) some healthy tissues are irradiated inevitably causing side effects, without being able to predict nowadays which patients will develop this toxicity. To date, the biomarker ...
Arce Gallego, Sara (Data de defensa: 2024-01-19)
[eng] Prostate cancer is the second most prevalent cancer among men. While early-stage has low mortality rates, metastatic castration-resistant prostate cancer (mCRPC) is a lethal form of the disease ...